Madam Speaker, I wonder if my colleague could provide her thoughts on how important it is that we work with the provinces to maximize the benefits of any sort of national pharmacare program.
At the very least, we owe it to the provinces to have those detailed discussions. Otherwise, if the federal government were to do it alone in some of the provinces that have taken a fairly strong stand, we would not have the same maximum benefit of a pharmacare program for Canadians from coast to coast to coast.